The study involves three episodes of treatment over a 12 week period using brain stimulation. Participants will undergo a screening and randomisation appointment to ensure they are safe to take part in the study with a doctor. They will be carefully monitored during the study by safety phone calls. Participants will undergo neurocognitive testing between treatments.